Q2 2017 Meddevicetracker Outlook Report

Our Early 2017 Outlook Report highlighted several high-impact catalysts. In this report, we cover catalysts from 14 devices expected to occur in Q2 2017. The last page of this report contains an excel sheet of the Large Impact Catalysts expected to occur in Q2 2017. For the full report please download the PDF version at the left of this page.

Like our report? Have any questions or feedback? Please let us know at [email protected]

Indications Covered:

• Cardiac Valve Surgery
• Congestive Heart Failure (CHF) and Cardiomyopathies
• Coronary Artery Disease
• Diabetes Mellitus, Type I and Type II
• Drug Delivery Technology (DDT)
• Reproductive Disorder
• Vaginal Atrophy
• Ventricular Tachycardia or Fibrillation